tripelennamine has been researched along with Chronic Disease in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ostrov, MR | 1 |
| Jacobi, KH | 1 |
2 other studies available for tripelennamine and Chronic Disease
| Article | Year |
|---|---|
Dramatic resolution of chronic urticaria.
Topics: Abscess; Adult; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Chronic Disease; Doxepin | 1995 |
[Chronic rhinitis and its treatment].
Topics: Alcohols; Allantoin; Chronic Disease; Humans; Hydantoins; Imidazoles; Naphazoline; Naphthalenes; Nas | 1969 |